GLP-1 medications typically cause weight loss, which may not be appropriate if you are already underweight or nutritionally compromised Gastrointestinal complications : Do you have strictures, fistulas, or a history of bowel obstruction
Emerging antiobesity drugs in development Numerous novel treatments for obesity are currently in the pipeline, including triple agonists that target GLP-1, GIP, and glucagon receptors [26]
The studies look promising
Patients and healthcare professionals may be unfamiliar with these medications, resulting in underutilization
Im surprised we dont see dragons flying in the skies with all the fairy-dusting youre spreading around
GLP-1 drugs heighten the incretin effect, reducing appetite and making it easier to stay in a caloric deficit for weight loss